Rein Therapeutics (RNTX) Institutional Ownership $1.11 -0.06 (-4.72%) As of 08/1/2025 03:59 PM Eastern Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Rein Therapeutics (NASDAQ:RNTX)CurrentInstitutional OwnershipPercentage90.89%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$849.80KNumber ofInstitutional Sellers(last 12 months)0 Get RNTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Rein Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Rein Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/31/2025 University of Texas Texas AM Investment Management Co.511,610$716K0.1%N/A2.310% 7/30/2025 Exencial Wealth Advisors LLC30,528$43K0.0%N/A0.138% 7/29/2025 Chicago Partners Investment Group LLC41,242$64K0.0%N/A0.186% 7/24/2025 Blair William & Co. IL23,622$33K0.0%N/A0.107% (Data available from 1/1/2016 forward) RNTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RNTX shares? During the previous two years, the following institutional investors and hedge funds held shares of Rein Therapeutics shares: University of Texas Texas AM Investment Management Co. ($716K), Chicago Partners Investment Group LLC ($64K), and Exencial Wealth Advisors LLC ($43K), Blair William & Co. IL ($33K).Learn more on Rein Therapeutics' institutional investors. What percentage of Rein Therapeutics' stock is owned by institutional investors? 90.89% of Rein Therapeutics' stock is owned by institutional investors. Learn more on RNTX's institutional investor holdings. Which institutional investors have been buying Rein Therapeutics' stock? The following institutional investors have purchased Rein Therapeutics' stock in the last 24 months: University of Texas Texas AM Investment Management Co. ($511.61K), Chicago Partners Investment Group LLC ($41.24K), Exencial Wealth Advisors LLC ($30.53K), and Blair William & Co. IL ($23.62K). How much institutional buying is happening at Rein Therapeutics? Institutional investors have bought a total of 607,002 shares in the last 24 months. This purchase volume represents approximately $849.80K in transactions. Related Companies BHST Institutional Ownership TARA Institutional Ownership IOBT Institutional Ownership FTLF Institutional Ownership SKYE Institutional Ownership HURA Institutional Ownership ALTS Institutional Ownership LXEO Institutional Ownership SAVA Institutional Ownership PLX Institutional Ownership This page (NASDAQ:RNTX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rein Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rein Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RNTX Stock Alerts